Sort by
Refine Your Search
-
, France, Italy and the UK. The aim of this research is to understand the emergence, spread and transmission of drug-resistant pathogens under the One Health concept, and to use this knowledge to develop
-
and understand mechanistic pathways related to drug-induced liver injury (DILI). You will have specific responsibility for delivering research, for developing research objectives and proposals. You will
-
Translational Centre for Rare Respiratory Diseases, a national initiative to transform the care of rare lung diseases including disease phenotyping, modelling, drug screening and clinical trials. The Clinical
-
most recently (iii) the application of these methods in chemical biology and drug discovery, and (iv) the application of these methods to problems in various disease settings including innate immunity
-
will focus on DNA repair targeted synthetic lethality and drug discovery in ovarian cancer. The project will include gene manipulation in ovarian cancer cell lines. Small molecular inhibitor studies and
-
targeted synthetic lethality and drug discovery in ovarian cancer. The project will include gene manipulation in ovarian cancer cell lines. Small molecular inhibitor studies and molecular biological
-
of the lung to provide novel understanding. This programme of research will improve the diagnosis, treatment and prevention of respiratory disease through mechanistic discoveries that identify new drug targets
-
chemical biology and drug discovery, and (iv) the application of these methods to problems in various disease settings including innate immunity, cancer, and host-pathogen interactions. This role will focus
-
and are each responsible for creating an inclusive community that is respectful and fair for all. Find out more about the benefits of working at the University and what it is like to live and work in